X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
reinduction (65) 65
humans (55) 55
female (48) 48
oncology (40) 40
male (39) 39
hematology (33) 33
adolescent (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
index medicus (27) 27
adult (25) 25
child (25) 25
child, preschool (24) 24
therapy (23) 23
children (21) 21
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (21) 21
chemotherapy (18) 18
infant (18) 18
relapse (18) 18
middle aged (17) 17
recurrence (17) 17
pediatrics (16) 16
acute lymphoblastic leukemia (15) 15
animals (15) 15
cancer (15) 15
reinduction therapy (15) 15
acute lymphoblastic-leukemia (13) 13
remission induction (13) 13
childhood (12) 12
treatment outcome (12) 12
rats (11) 11
retrospective studies (11) 11
time factors (11) 11
aged (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
cytarabine - administration & dosage (10) 10
pharmacokinetics (10) 10
antineoplastic agents - therapeutic use (9) 9
acute lymphocytic leukemia (8) 8
acute myelogenous leukemia (7) 7
asparaginase (7) 7
asparaginase - administration & dosage (7) 7
asparaginase - therapeutic use (7) 7
drug administration schedule (7) 7
immunology (7) 7
leukemia, myeloid, acute - drug therapy (7) 7
mitoxantrone (7) 7
prognosis (7) 7
remission (7) 7
salvage therapy (7) 7
acute lymphoblastic leukaemia (6) 6
acute lymphocytic-leukemia (6) 6
acute myeloid leukemia (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
cells (6) 6
cisplatin (6) 6
consolidation therapy (6) 6
cytarabine (6) 6
cytosine-arabinoside (6) 6
dose-response relationship, drug (6) 6
erwinia asparaginase (6) 6
experimental allergic encephalomyelitis (6) 6
hypersensitivity (6) 6
idarubicin (6) 6
induction (6) 6
medicine & public health (6) 6
precursor cell lymphoblastic leukemia-lymphoma - pathology (6) 6
rats, inbred lew (6) 6
reinduction chemotherapy (6) 6
adults (5) 5
aml (5) 5
asparaginase - blood (5) 5
asparaginase - pharmacokinetics (5) 5
combined modality therapy (5) 5
disease (5) 5
encephalomyelitis, autoimmune, experimental - immunology (5) 5
experience (5) 5
hematopoietic stem cell transplantation (5) 5
myelin basic protein - immunology (5) 5
oncaspar (5) 5
pathology (5) 5
precursor cell lymphoblastic leukemia-lymphoma - blood (5) 5
precursor cell lymphoblastic leukemia-lymphoma - therapy (5) 5
resistance (5) 5
survival (5) 5
survival analysis (5) 5
tolerance (5) 5
transplantation (5) 5
acute myeloid-leukemia (4) 4
aged, 80 and over (4) 4
analysis (4) 4
carcinoma (4) 4
central pontine myelinolysis (4) 4
combination chemotherapy (4) 4
cyclophosphamide (4) 4
disease-free survival (4) 4
diseases (4) 4
dosage and administration (4) 4
drug hypersensitivity - etiology (4) 4
escherichia-coli (4) 4
fludarabine (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia & Lymphoma, ISSN 1042-8194, 06/2019, Volume 60, Issue 7, pp. 1749 - 1757
We conducted a retrospective study of 364 acute myeloid leukemia patients treated using a Day14 or a noDay14 strategy. Under the Day14 strategy, patients... 
Day14 marrow | Acute myeloid leukemia | induction chemotherapy | early reinduction | delayed reinduction | AML | DIAGNOSIS | REMISSION INDUCTION THERAPY | BIOPSY | BLAST CLEARANCE | REGIMEN | CHEMOTHERAPY | ACHIEVEMENT | ONCOLOGY | RECOMMENDATIONS | CONSOLIDATION THERAPY | HEMATOLOGY
Journal Article
PEDIATRIC BLOOD & CANCER, ISSN 1545-5009, 11/2016, Volume 63, Issue 11, pp. 1943 - 1948
Background: The UK ALLR3 (R3) regimen has been adopted to treat pediatric relapsed acute lymphoblastic leukemia (ALL) by many centers in the United States and... 
SURVIVAL | INFECTIONS | BONE-MARROW | adverse events | reinduction | CANCER | CHILDREN | relapsed ALL | RELAPSE | PROPHYLAXIS | DISEASES | ONCOLOGY | PEDIATRICS | THERAPEUTIC ADVANCES | HEMATOLOGY | FLUCONAZOLE
Journal Article
Journal Article
Journal Article
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, ISSN 2035-3006, 05/2019, Volume 11, Issue 1, p. e2019032
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 2002, Volume 9, Issue 5, pp. 486 - 492
Journal Article
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 03/2008, Volume 3, Issue 2, pp. 331 - 336
Journal Article
Journal of pediatric hematology/oncology, ISSN 1077-4114, 12/2011, Volume 33, Issue 8, pp. 610 - 616
Administration of L-asparaginase is limited by hypersensitivity reactions mediated by anti-asparaginase antibodies. To overcome this problem, native E. coli... 
Relapsed Acute Lymphoblastic Leukemia (ALL) | Reinduction chemotherapy | Hypersensitivity | Asparaginase
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 02/2017, Volume 64, Issue 2, pp. 234 - 241
Journal Article
Journal Article
BLOOD, ISSN 0006-4971, 11/2011, Volume 118, Issue 22, pp. 5774 - 5782
Hypersensitivity reactions limit the use of the antileukemic enzyme asparaginase (ASE). We evaluated Ab levels against Escherichia coli ASE and ASE activity in... 
THERAPY | PHARMACOKINETICS | ACUTE LYMPHOBLASTIC-LEUKEMIA | ERWINIA ASPARAGINASE | REINDUCTION | LYMPHOMA | PHARMACODYNAMICS | ONCASPAR(TM) | HEMATOLOGY | CHILDREN | HYPERSENSITIVITY | Drug Hypersensitivity - blood | Recombinant Proteins - therapeutic use | Humans | Child, Preschool | Infant | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Drug Monitoring - methods | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Prednisone - immunology | Drug Hypersensitivity - diagnosis | Adult | Escherichia coli Proteins - immunology | Retrospective Studies | Chemotherapy, Adjuvant | Asparaginase - therapeutic use | Child | Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood | Daunorubicin - therapeutic use | Escherichia coli - enzymology | Antineoplastic Agents - immunology | Escherichia coli - immunology | Vincristine - immunology | Daunorubicin - immunology | Antineoplastic Combined Chemotherapy Protocols - immunology | Recombinant Proteins - administration & dosage | Biomarkers, Pharmacological - blood | Randomized Controlled Trials as Topic | Asparaginase - administration & dosage | Asparaginase - immunology | Recombinant Proteins - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Drug Hypersensitivity - immunology | Adolescent | Vincristine - therapeutic use | Antibodies - blood | Prednisone - therapeutic use
Journal Article
Revue des Maladies Respiratoires Actualites, ISSN 1877-1203, 2014, Volume 6, Issue 2, pp. 148 - 150
The standard first-line treatment of small cell lung cancer is well known, and has remained the same for around twenty years. Advances have generally been made... 
Reinduction | Non small cell lung cancer | Cisplatine | Etoposide | Topotecan
Journal Article